Go Pro

Century Therapeutics (IPSC) Institutional Ownership

Century Therapeutics logo
$1.92 -0.01 (-0.52%)
Closing price 04:00 PM Eastern
Extended Trading
$1.93 +0.01 (+0.47%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Century Therapeutics (NASDAQ:IPSC)

Current
Institutional Ownership
Percentage
50.20%
Number of
Institutional Buyers
(last 12 months)
26
Total
Institutional Inflows
(last 12 months)
$104.78M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$2.48M
Get IPSC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Century Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IPSC Institutional Buying and Selling by Quarter

Century Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2026Legal & General Group Plc43,960$108K0.0%N/A0.024%
8/14/2026The Manufacturers Life Insurance Company 34,602$85K0.0%N/A0.019%
8/14/2026 Spruce Street Capital LP4,059,054$9.94B2.0%N/A2.251%
8/7/2026 BlackRock Inc.8,091,768$19.83M0.0%N/A4.487%
8/7/2026 Deutsche Bank AG120,234$295K0.0%N/A0.067%
8/6/2026 Bank of New York Mellon Corp299,014$733K0.0%N/A0.166%
8/6/2026 State of Wyoming33,425$82K0.0%N/A0.019%
8/6/2026 GSA Capital Partners LLP120,598$295K0.0%N/A0.067%
6/4/2026Seven Fleet Capital Management LP4,347,826$9.83M3.1%N/A2.411%
6/3/2026DV Trading LLC1,400,000$3.16M0.1%N/A0.776%
5/19/2026Bank of America Corp DE145,099$328K0.0%+27,537.9%0.080%
5/18/2026Rock Springs Capital Management LP1,304,347$2.95M0.2%N/A0.723%
5/15/2026Commodore Capital LP8,695,652$19.65M1.1%N/A4.821%
5/15/2026 OMERS ADMINISTRATION Corp47,800$108K0.0%N/A0.027%
5/15/2026 Spruce Street Capital LP4,059,054$9.17M2.2%+185.5%2.251%
5/14/2026 Renaissance Technologies LLC906,827$2.05M0.0%-32.8%0.503%
5/7/2026 Dimensional Fund Advisors LP55,183$122K0.0%N/A0.031%
5/6/2026 Quadrant Private Wealth Management LLC20,022$45K0.0%+31.0%0.011%
5/5/2026 Versant Venture Management LLC12,166,109$27.50M19.4%N/A6.746%
5/5/2026 Bank of New York Mellon Corp12,897$29K0.0%N/A0.007%
4/21/2026 Cannon Global Investment Management LLC49,000$111K0.2%N/A0.027%
2/18/2026Millennium Management LLC610,387$607K0.0%-17.9%0.698%
2/17/2026Adage Capital Partners GP L.L.C.1,838,700$1.83M0.0%N/A2.104%
2/16/2026 Spruce Street Capital LP1,421,532$1.41M0.5%N/A1.626%
2/12/2026Jane Street Group LLC45,194$45K0.0%-23.1%0.052%
2/12/2026 Renaissance Technologies LLC1,349,200$1.34M0.0%-47.8%1.544%
2/9/2026 Geode Capital Management LLC456,115$454K0.0%+2.4%0.522%
11/17/2025Susquehanna International Group LLP67,924$34K0.0%-66.0%0.079%
11/17/2025Millennium Management LLC743,781$370K0.0%-8.4%0.861%
11/17/2025Citadel Advisors LLC360,825$180K0.0%+64.1%0.418%
11/14/2025Two Sigma Investments LP911,446$454K0.0%+59.2%1.055%
11/14/2025Squarepoint Ops LLC236,053$118K0.0%+483.1%0.273%
11/7/2025 GSA Capital Partners LLP603,479$301K0.0%+29.3%0.699%
8/14/2025Jane Street Group LLC444,590$248K0.0%N/A0.516%
8/14/2025Raymond James Financial Inc.91,323$51K0.0%N/A0.106%
8/14/2025Qube Research & Technologies Ltd67,737$38K0.0%N/A0.079%
8/13/2025 Marshall Wace LLP139,707$78K0.0%N/A0.162%
8/12/2025 Prudential Financial Inc.45,400$25K0.0%N/A0.053%
8/8/2025 Geode Capital Management LLC380,277$213K0.0%-60.8%0.441%
8/1/2025 Y Intercept Hong Kong Ltd89,975$50K0.0%N/A0.104%
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
6/27/2025Goldman Sachs Group Inc.179,635$86K0.0%+26.9%0.208%
5/21/2025Acadian Asset Management LLC284,229$133K0.0%+101.2%0.330%
5/16/2025Goldman Sachs Group Inc.179,635$86K0.0%+26.9%0.208%
5/16/2025AQR Capital Management LLC111,079$53K0.0%+358.9%0.129%
5/15/2025Baker BROS. Advisors LP241,684$115K0.0%-69.7%0.281%
5/12/2025Nuveen LLC157,311$75K0.0%N/A0.183%
5/9/2025Deutsche Bank AG96,140$46K0.0%-50.3%0.112%
5/9/2025Charles Schwab Investment Management Inc.270,820$129K0.0%-24.3%0.314%
2/17/2025VR Adviser LLC3,957,186$4.00M0.3%-26.6%4.654%
2/17/2025Squarepoint Ops LLC164,871$167K0.0%+56.0%0.194%
2/17/2025Two Sigma Investments LP66,797$67K0.0%N/A0.079%
2/17/2025Two Sigma Advisers LP51,000$52K0.0%N/A0.060%
2/17/2025Nuveen Asset Management LLC157,311$159K0.0%+48.9%0.185%
2/17/2025Millennium Management LLC1,607,174$1.62M0.0%+1,041.8%1.890%
2/17/2025Deutsche Bank AG193,368$195K0.0%+890.7%0.227%
2/17/2025Casdin Capital LLC5,190,506$5.24M0.3%+61.6%6.104%
2/17/2025Bank of America Corp DE66,043$67K0.0%+109.1%0.078%
2/14/2025Jane Street Group LLC48,036$49K0.0%+166.2%0.056%
2/14/2025Northern Trust Corp336,989$340K0.0%-4.4%0.396%
2/13/2025Marshall Wace LLP35,511$36K0.0%N/A0.042%
2/13/2025XTX Topco Ltd85,993$87K0.0%N/A0.101%
2/13/2025Renaissance Technologies LLC1,202,885$1.22M0.0%+146.4%1.415%
2/12/2025Geode Capital Management LLC991,595$1.00M0.0%+2.4%1.166%
2/12/2025JPMorgan Chase & Co.163,189$165K0.0%+127.5%0.192%
2/11/2025Sei Investments Co.52,748$53K0.0%N/A0.062%
12/26/2024JPMorgan Chase & Co.71,721$123K0.0%+257.6%0.084%
11/19/2024Barclays PLC61,945$106K0.0%+283.6%0.073%
11/16/2024Geode Capital Management LLC968,182$1.66M0.0%+3.5%1.139%
11/15/2024Barclays PLC61,945$106K0.0%+283.6%0.073%
11/15/2024Jane Street Group LLC18,044$31K0.0%-77.6%0.021%
11/15/2024Wellington Management Group LLP166,123$284K0.0%N/A0.195%
11/15/2024State Street Corp836,914$1.43M0.0%+7.4%0.984%
11/13/2024FMR LLC2,521,511$4.31M0.0%-14.5%2.965%
11/12/2024Charles Schwab Investment Management Inc.355,331$608K0.0%-10.8%0.418%
11/6/2024Cornercap Investment Counsel Inc.25,978$44K0.0%-49.1%0.031%
10/3/2024SG Americas Securities LLC16,081$27K0.0%N/A0.019%
8/9/2024Renaissance Technologies LLC165,500$422K0.0%+6.1%0.196%
8/9/2024Dimensional Fund Advisors LP75,315$192K0.0%+141.7%0.089%
8/8/2024Federated Hermes Inc.276,163$704K0.0%-55.1%0.327%
8/1/2024Rhumbline Advisers52,466$134K0.0%+56.0%0.062%
7/26/2024Bank of New York Mellon Corp149,000$380K0.0%+110.1%0.176%
5/16/2024Jacobs Levy Equity Management Inc.293,941$1.23M0.0%+191.0%0.453%
5/10/2024Vanguard Group Inc.1,138,653$4.76M0.0%+1.2%1.757%
5/1/2024Mirae Asset Global Investments Co. Ltd.11,130$47K0.0%N/A0.017%
2/28/2024Abel Hall LLC10,071$33K0.0%N/A0.017%
2/14/2024Avidity Partners Management LP1,355,000$4.50M0.2%+23.4%2.265%
2/6/2024New York Life Investment Management LLC99,912$332K0.0%-2.6%0.167%
1/31/2024Federated Hermes Inc.618,482$2.05M0.0%+0.4%1.034%
11/14/2023Avidity Partners Management LP1,098,500$2.20M0.1%-1.1%1.836%
11/13/2023FMR LLC4,524,629$9.05M0.0%-12.5%7.562%
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (Ad)

In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon adviser Jim Rickards publicly predicted a Trump victory before election night. Now Rickards is issuing a new forecast he calls a potential mid-term meltdown, one he believes could send shockwaves through financial markets.tc pixel

See Jim Rickards' full market warning and what it means for your portfolio
11/8/2023New York Life Investment Management LLC102,606$205K0.0%-13.6%0.172%
8/7/2023Acadian Asset Management LLC50,078$157K0.0%-18.6%0.084%
8/7/2023New York Life Investment Management LLC118,771$375K0.0%-11.3%0.199%
5/12/2023Martingale Asset Management L P49,151$171K0.0%N/A0.082%
5/11/2023Cornercap Investment Counsel Inc.52,175$181K0.0%N/A0.088%
5/9/2023Gladius Capital Management LP7,730$27K0.0%N/A0.013%
5/8/2023New York Life Investment Management LLC133,829$464K0.0%N/A0.225%
2/9/2023Mirae Asset Global Investments Co. Ltd.12,622$65K0.0%N/A0.021%
2/2/2023SG Americas Securities LLC10,368$53K0.0%N/A0.018%
1/23/2023Allspring Global Investments Holdings LLC7,992$41K0.0%N/A0.014%


IPSC Institutional Ownership - Frequently Asked Questions

During the previous two years, 52 institutional investors and hedge funds held shares of Century Therapeutics. The most heavily invested institutionals were Spruce Street Capital LP ($9.94B), Versant Venture Management LLC ($27.50M), BlackRock Inc. ($19.83M), Commodore Capital LP ($19.65M), Seven Fleet Capital Management LP ($9.83M), Casdin Capital LLC ($5.24M), and FMR LLC ($4.31M).Learn more on Century Therapeutics' institutional investors.

50.20% of Century Therapeutics' stock is owned by institutional investors. Learn more on IPSC's institutional investor holdings.

Of the 45 institutional investors that purchased Century Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Versant Venture Management LLC ($12.17M), Commodore Capital LP ($8.70M), Spruce Street Capital LP ($8.12M), BlackRock Inc. ($8.09M), Seven Fleet Capital Management LP ($4.35M), Casdin Capital LLC ($1.98M), and Adage Capital Partners GP L.L.C. ($1.84M).

Institutional investors have bought a total of 47,751,578 shares in the last 24 months. This purchase volume represents approximately $104.78M in transactions.

The following institutional investors have sold Century Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($1.68M), Millennium Management LLC ($201.83K), Susquehanna International Group LLP ($132.03K), and Jane Street Group LLC ($13.54K).

Institutional investors have sold a total of 2,027,464 shares in the last 24 months. This volume of shares sold represents approximately $2.48M in transactions.



Institutional ownership data for NASDAQ:IPSC is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners